In a chaotic meeting, RFK Jr.'s vaccine panel voted against requiring prescriptions for Covid-19 shots. Confusion reigned as panelists struggled with their roles, raising questions about vaccine safety and governance.
Tech stocks are on the rise! Nvidia's $100 million investment in OpenAI fuels optimism, while companies like Teradyne and Oracle see significant gains. Find out what's driving the market today!
Getting a COVID vaccine is tougher this year due to new FDA approvals limiting eligibility. If you're struggling to find a shot, read on for essential information on risk factors and where to get vaccinated.
The FDA has approved new Covid vaccines, but confusion surrounds eligibility and coverage. Find out who can get vaccinated and how the new vaccines target the latest strains.
A new vaccine policy has been announced, allowing boosters for high-risk patients while leaving healthy adults and children in a gray area. Experts warn this could lead to fewer vaccinations and rising COVID-19 cases.
In a major shift, the FDA has approved updated Covid boosters while restricting access for children under 5, raising concerns among parents and health experts. Learn about the new guidelines and their implications.
As U.S. stocks ended the week with mixed results, the Michigan Consumer Sentiment Index revealed a drop in economic confidence. UnitedHealth saw a surge after Berkshire Hathaway increased its stake, while Sunrun soared on strong earnings. Get the full market recap!
Discover how researchers at IBM and Moderna have leveraged quantum computing to predict the complex protein structure of mRNA, marking a significant advancement in vaccine technology.
The FDA has updated warnings about potential cardiac risks associated with Pfizer and Moderna COVID-19 vaccines, especially for young men. Learn what the new labels say and what it means for vaccine safety.
The S&P 500 saw major movements with Palantir and Moderna stocks rising sharply, while Lululemon faced a significant decline in share value. Analysts weigh in on Tesla and Broadcom's performance amid market shifts.
